Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder.
Open Access
- 19 May 2020
- journal article
- editorial
- Published by Elsevier BV in Multiple Sclerosis and Related Disorders
- Vol. 44, 102199
- https://doi.org/10.1016/j.msard.2020.102199
Abstract
No abstract availableKeywords
Funding Information
- Biogen
This publication has 21 references indexed in Scilit:
- Treatment of rituximab-associated chronic CNS enterovirus using IVIg and fluoxetineNeurology, 2019
- Neurologic Alterations Due to Respiratory Virus InfectionsFrontiers in Cellular Neuroscience, 2018
- A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosusTherapeutics and Clinical Risk Management, 2018
- Fatal Powassan Encephalitis (Deer Tick Virus, Lineage II) in a Patient With Fever and Orchitis Receiving RituximabJAMA Neurology, 2018
- Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare eventJournal of NeuroVirology, 2018
- Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and PreventionOpen Forum Infectious Diseases, 2017
- West Nile Virus Central Nervous System Infection in Patients Treated With Rituximab: Implications for Diagnosis and Prognosis, With a Review of LiteratureOpen Forum Infectious Diseases, 2015
- JC polyomavirus granule cell neuronopathy in a patient treated with rituximab.JAMA Neurology, 2014
- Fatal Case of Enterovirus 71 Infection and Rituximab Therapy, France, 2012Emerging Infectious Diseases, 2013
- Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatmentBlood, 2011